Comparing Palliative Care in Care Homes Across Europe (PACE): Protocol of a Cross-sectional Study of Deceased Residents in 6 EU Countries  by Van den Block, Lieve et al.
JAMDA 17 (2016) 566.e1e566.e7JAMDA
journal homepage: www.jamda.comLong-Term Care Around the GlobeComparing Palliative Care in Care Homes Across Europe (PACE):
Protocol of a Cross-sectional Study of Deceased Residents in 6 EU
Countries
Lieve Van den Block PhD a,*, Tinne Smets MSc a, Nanja van Dop MSc a,
Eddy Adang PhD b, Paula Andreasen MIH c, Danni Collingridge Moore MSc d,
Yvonne Engels PhD e, Harriet Finne-Soveri PhD c, Katherine Froggatt PhD d,
Giovanni Gambassi PhD f, Violetta Kijowska MSc g,
Bregje Onwuteaka-Philipsen PhD h, H. Roeline Pasman PhDh, Sheila Payne PhD d,
Ruth Piers PhD a,i, Katarzyna Szczerbinska PhD g, Maud ten Koppel MSc h,
Nele Van Den Noortgate PhD a,i, Jenny T. van der Steen PhD h,
Myrra Vernooij-Dassen PhD j, Luc Deliens PhD a,k on behalf of PACEy
aDepartment of Family Medicine and Chronic Care, End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Brussels,
Belgium
bDepartment of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands
cNational Institute for Health and Welfare, Helsinki, Finland
d International Observatory on End-of-Life Care, Lancaster University, Lancaster, United Kingdom
eDepartment of Anesthesiology, Pain, and Palliative Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
fUniversità Cattolica del Sacro Cuoro, Rome, Italy
gUnit for Research on Aging Society, Department of Sociology of Medicine, Epidemiology and Preventive Medicine Chair, Faculty of Medicine,
Jagiellonian University Medical College, Krakow, Poland
h EMGO Institute for Health and Care research, Expertise Center for Palliative Care, VU University Medical Center, Amsterdam, the Netherlands
iDepartment of Geriatric Medicine, Ghent University Hospital, Ghent, Belgium
jRadboud University Medical Center, IQ healthcare, Nijmegen, the Netherlands
kDepartment of Medical Oncology, Ghent University Hospital, Ghent, BelgiumKeywords:
Palliative care
care home
nursing home
European
quality of end-of-life careThe authors declare no conﬂicts of interest.
The research leading to these results received
Union’s Seventh Framework Programme (FP7/ 2007e
603111 (PACE project Palliative Care for Older People
study design, collection, analysis or interpretation of
the decision to submit this article for publication.
* Address correspondence to Lieve Van den Block, P
(VUB), Faculty of Medicine and Pharmacy, Laarbe
Belgium.
http://dx.doi.org/10.1016/j.jamda.2016.03.008
1525-8610/ 2016 AMDA e The Society for Post-Acute
org/licenses/by-nc-nd/4.0/).a b s t r a c t
Objectives: Although a growing number of older people are dying in care homes, palliative care has
developed in these settings only recently. Cross-country representative comparative research hardly
exists in this area. As part of a large EU-funded project, we aim to undertake representative comparative
research in care homes in Europe, to describe and compare 6 countries in terms of (1) resident outcomes,
quality and costs of palliative and end-of-life care; and (2) palliative care structures and staff knowledge
and attitudes toward palliative care. We also aim to explore country, facility, staff, patient, and care
characteristics related to better outcomes at resident level.
Design and Methods: To obtain a representative nationwide sample, we will conduct a large-scale cross-
sectional study of deceased residents in care homes in Belgium, Finland, Italy, the Netherlands, Poland,
and the United Kingdom, using proportional stratiﬁed random sampling (taking into account region,
facility type and bed capacity). In each country, all participating care homes retrospectively report all
deaths of residents in and outside the facilities over the previous 3-month period. For each case,
structured questionnaires, including validated instruments, are sent to (1) the administrator/manager,funding from the European
2013) under grant agreement
). The funders had no role in
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L. Van den Block et al. / JAMDA 17 (2016) 566.e1e566.e7566.e2(2) staff member most involved in care, (3) treating physician (general practitioner or elderly care
physician), and (4) a closely involved relative. It is estimated that, per country, 50 care homes are needed
on average to obtain a minimum of 200 deceased residents. Collected data include clinical and socio-
demographic characteristics, quality of dying, quality and costs of palliative care and end-of-life care, and
palliative care structures at the facility level and country level. To obtain a representative view of staff
knowledge and attitudes regarding palliative care, PACE will conduct a cross-sectional study of staff
working in the participating care homes.
Conclusion: Considering the growing challenges associated with aging in all European countries, there is
an urgent need to build a robust international comparative evidence base that can inform the devel-
opment of policies to target improved palliative care in care homes. By describing this research protocol,
we hope to inform international research in care homes on how to perform representative end-of-life
care research in these settings and better understand which systems are associated with better
outcomes.
 2016 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Societies in the European Union (EU) are aging, leading to the need Speciﬁc research questions are as follows:
not only to improve health by prevention but also to improve people’s
quality of life and enabling them to live and die well.1,2 The proportion
of the world’s population older than 60 years is expected to double
from approximately 11% to 22% between 2000 and 2050. More people
will die in late old age following a slow dying course with multiple
chronic diseases, years of disability, and complex palliative care
needs.2,3 The number of people living with dementia worldwide is
estimated to double to 65.7 million by 2030 and triple to 115.4 million
by 2050.1,4 These developments have great clinical, societal, and so-
cioeconomic implications common to all EU countries.
Although health policies in many countries aim to enable people to
live in their own homes, many older people will require long-term
institutional care at the end of life. A signiﬁcant proportion of older
people also die in care homes (nursing homes or homes for older people
or other long-term care facilities): from one-sixth in Italy to one-third in
the Netherlands.5,6 However, a number of descriptive studies suggest
that end-of-life care and quality of dying in these settings can be less
than optimal for older people and their families. Symptoms appear
underestimated and there is a risk of overtreatment that is continuing
life-prolonging, burdensome treatments without knowing individual
preferences, or of being transferred to a hospital in the last days of
life.1,3,7e11 Recent reviews also show there is lack of knowledge about
which palliative care systems exist in care homes in Europe and how
effective they are in producing high-quality end-of-life care.11,12
Although examples of good practice have been documented, palliative
care in care homes has not been systematically developed across
Europe.1,6 Although in some countries palliative care is highly devel-
oped in care homes, other countries lack this and rely on the standard
care available for these settings. There is no solid evidence about which
care system best fulﬁlls the complex needs of older people at the end of
life.11,12 Most studies are descriptive, small scale, or focused on speciﬁc
diseases. Also, most existing research identifying the need for
improving palliative care in care homes is limited to only one country or
region within a country.11,13e16 Thus, we lack large-scale representative
and cross-country studies in this area. Additionally, economic evalua-
tions of palliative care are relatively rare. Evidence-based evaluations
and comparative EU studies of quality and cost of palliative care are
needed to help guide decisions in health care.1,3,11,17
PACE (Palliative Care for Older People) is an EU-funded project
(2014e2019) that aims to undertake comparative representative
research on dying in care homes in Europe. This protocol focuses on
one major study within PACE that aims to describe and compare 6
countries (Belgium, Finland, Italy, the Netherlands, Poland, United
Kingdom) in terms of resident outcomes, quality and costs of
palliative/end-of-life care, palliative care structures/systems, and
staff knowledge and attitudes toward palliative care, and aims to
unpack the relationship among these structures, processes, and
outcomes.1. To what extent do Belgium, Finland, Italy, the Netherlands,
Poland, and the United Kingdom differ in terms of resident
outcomes (quality of dying), and quality and costs of palliative/
end-of-life care?
2. To what extent do countries differ in terms of palliative care
structures/systems and palliative care knowledge and attitudes
of staff?
3. To what extent are country, facility, staff, patient, and care
characteristics (structures and processes) related to better
outcomes (ie, better quality of dying)?
In this article, we outline the research design and methodology
developed to answer these research questions. By describing our
epidemiological approach, we hope to inform international research
methodologies in care homes, in particular on how to perform
representative end-of-life care research in these settings, better un-
derstand which systems are associated with better outcomes, and use
cross-country comparisons to identify areas for improvement in cur-
rent practice.
Methods
Design
To obtain representative nationwide samples, PACE will conduct a
cross-sectional study of deceased residents in care homes in Belgium,
Italy, Finland, the Netherlands, Poland, and the United Kingdom, using
proportional stratiﬁed random sampling. In each country, all partici-
pating care homes retrospectively report all deaths of residents (ie,
people who are registered as a resident in the facility records) in and
outside the facilities over the previous 3-month period. Although a
retrospective design may limit the ability to retrieve certain aspects of
the treatment histories of deceased patients,18 it has been identiﬁed as
the most appropriate design to identify a representative sample of
deceased residents.19 Prognostication on dying in prospective follow-
up research is problematic,20,21 and all patients cannot be followed
until death, resulting in patients living longer being underrepre-
sented.21,22 Using a 3-month period limits recall bias and has been
successfully tested in previous research.13,14,19,23
Additionally, to obtain a representative view of staff knowledge and
attitudes regarding palliative care, we will conduct a cross-sectional
study of staff (care assistants, nurses) working in the participating
homes.
Setting and Participants
Throughout this project, the term “care homes” is used for all “col-
lective institutional settings where care, on-site provision of personal
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of nursing andmedical care, is provided for older peoplewho live there,
24 hours a day, 7 days a week, for an undeﬁned period of time.”6 Three
types of care homes can be differentiated within PACE countries, as
shown in Table 1, with a variety of labels used throughout the coun-
tries.6 Across the different countries, there is also quite some variation
in organizational funding structureswith differential reliance onpublic,
not-for-proﬁt, and private sectors (Figure 1). Data provided in Table 1
and Figure 1 came from a country mapping survey ﬁlled in by con-
sortium members, identical to the one used in a previous European
survey concerning palliative care development in care homes.6
For each deceased resident identiﬁed in the participating care
homes, structured questionnaires including validated instruments
will be sent to the (1) administrator/manager, (2) staff member most
involved in care (preferably a nurse), (3) treating physician (general
practitioner [GP] or elderly care physician), and (4) a most closely
involved relative (family or friend). For each care home participating
in the study, a facility questionnaire will be ﬁlled in by the adminis-
trator/manager. Additionally, all care home staff (care assistants,
nurses, head nurses) employed in the care home and on duty at the
time the researcher visits the facility will be asked to ﬁll in a separate
questionnaire on knowledge and attitudes (not linked to a particular
resident).Sampling and Data Collection Procedures
Sampling procedures will be speciﬁed per country. In each country
that can use national lists of certiﬁed care homes, facilities will be
stratiﬁed by region (provinces or other large regions depending on the
country) and subsequently by facility type (see Table 1) and bed ca-
pacity (above and below the median number of beds in care homes in
the country) and then sampled randomly to cover the entire country.
In addition, in the United Kingdom, the specialist research network for
care homes (ENRICH) will be involved in highlighting the study to its
members. In Italy, where no public lists of the more than 8000 care
homes are available, a previously constructed cluster of care homes
interested in participating in research will be used. This convenience
sample of care homes includes facilities from 15 of 21 regions, covers
the 3 macro regional areas (North, Center, and South) of Italy, and
takes into consideration the regional differences in terms of facility
size (number of beds) and their characteristics (type, organizational
status). A similar strategy was used in previous Italian care home
studies including the EU SHELTER project.24Table 1
Types of Care Homes in PACE Countries
Type 1 Care Homes With On-Site Care From
Physicians,* Nurses, Care Assistants
Type 2 Care
Nurses, Care
From Physic
Available (Y)
or Not (N)
Label Used Available (Y
or Not (N)
Belgium N Not applicable Y
Finland Y Long-term care
facilities with 24/7 care
Y
Italy Y Nursing homes (RSA) Y
The Netherlands Y Nursing homes
(“verpleeghuizen”)
Y
Poland Y Care and treatment
centers (ZOL)
Care and nursing
centers (ZPO)
Y
United Kingdom N Not applicable Y
*GPs or other elderly care physicians.Data collection procedures are described in detail in a quality
assurance manual to ensure high-quality processes are adhered to. All
researchers involved in PACE will be trained extensively by the coor-
dinator to ensure data collection procedures are followed as instructed.
Step 1: A letter introducing the project will be sent to the board of
directors/owner/manager asking for voluntary participation (without
reimbursement) and telephone or e-mail contact is made.
Step 2: In each participating care home, one contact person for the
study (an administrator, head nurse, or manager) will be appointed.
Step 3: The researcher will visit each participating care home and
assist the contact person, using structured checklists, in identifying
the following:
- all deceased residents (in or outside the care home) over the
previous 3 months
- key respondents for each deceased resident (staff member,
treating physician, and relative)
- all employed nursing and care staff present or on duty at the
day of the visit
- a key person from the care home management (administrator
or manager)
The checklists will be ﬁlled in by the contact person using the
administrative ﬁles and consists of a part A containing identiﬁable
names of residents and respondents (to be kept in the facility and
never accessible to the researchers), and a part B with unique pseu-
donomized codes.
Step 4: The structured checklists will be used to prepare the
questionnaires and prestamped envelopes, and distributed or mailed
by the contact person. The questionnaires contain only anonymous
codes and will be sent back directly to the researchers (not to the
facility or contact person).The relatives will receive the questionnaire
at least 2 weeks to 3 months after the resident’s death, depending on
what is allowed in each country (as advised by the approving ethics
committees). All questionnaires will be accompanied by a letter con-
taining information about the study.
Step 5: The facility questionnaire will be ﬁlled in by a key person of
the management during the visit, who may need to consult other staff
members to gather all requested information about the facility.
Step 6: The researchers will continuously monitor incoming
questionnaires using Excel ﬁles. Up to 2 reminders (after 3 weeks)
will be sent to physicians, staff, and relatives via the contact person
in the facilities, except in Poland and the United Kingdom where
relatives will receive 1 reminder (following ethics committees’
requirements).Homes With On-Site Care From
Assistants, But Off-Site Care
ians
Type 3 Care Homes With On-Site Care From
Care Assistants, But Off-Site Care Nurses and
Physicians
) Label Used Available (Y)
or Not (N)
Label Used
Nursing homes
(“woonzorgcentra”)
N Not applicable
Long-term care facilities
with 24/7 care
N Not applicable
Homes for older people N Not applicable
Residential homes
(“verzorgingshuizen”)
N Not applicable
Residential homes (DPS) Y Residential homes (DPS)
Care homes (nursing) Y Care homes (residential)
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Fig. 1. Care home providers by organizational status.
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Table 2 provides an overview of all measures and instruments used
in the study.
Translations
The consortium will use strict procedures for forward-backward
translations of questions or questionnaires that are not ofﬁcially
translated in earlier studies, following guidelines from the EORTC25:
English will be the source language; forward translation will be per-
formed in each country with 2 translators/native speakers with a high
level of proﬁciency in English; the principal investigator (PI) of each
country will merge them into one single forward translation in
consultation with the translators; 2 other translators/native English
speakers with high level of knowledge of the target language will
perform the backward translations independently; and the PI will
compare these translations with the original questionnaires and
discuss any identiﬁed problems with the translators. All results and
problems are discussed in the PACE consortium to reach a consensus.
Feasibility Testing
After all translations are ﬁnalized, each country will test all ques-
tionnaires, materials, and data collection procedures in 3 care homes
per country (excluded from the main data collection). The question-
naires for physicians and relatives are to be tested separately by
contacting 3 GPs/elderly care physicians and 3 relatives recruited by
the researchers. All questionnaires are tested in a face-to-face manner
for comprehensiveness, length, and lay-out. In the United Kingdom,
feasibility was judged in consultation with stakeholders in the ﬁeld,
without contacting relatives. The reports of the feasibility testing are
discussed in the consortium to make decisions about the ﬁnal ques-
tionnaires and procedures.
Estimated Sample Sizes
Power calculation was aimed at comparing 2 countries with each
other. Assuming coefﬁcient of variation of true means between care
homes within each country of 0.09, group sample sizes of 12 long-
term care facilities (LTCFs) times 4 deaths (¼48) achieve 90% power to
detect a difference of e5.2 in quality of dying (CAD-EOLD scale) with
estimated group SDs of 6.13 and 4.67, and a¼ 0.0540 CAD-EOLD scores
are based on comparative BE-NL study.26 Based on average length of
stay and size of facilities in the 6 countries, we estimated averagenumber of deaths over a 3-month period across the care homes is at
least 4 (Belgium n ¼ 5, Finland ¼ 4, Italy ¼ 10, Netherlands ¼ 4,
Poland ¼ 5, United Kingdom ¼ 4 to 12 depending on type of care
home). Estimating the number of people with at least moderate de-
mentia at time of death at 50% and taking into account a nonresponse
of 20% for staff but 50% for relatives, PACE aims to include a minimum
of 48 care homes (¼12*2*2) per country to identify at least 192
deceased residents per country or 1152 deceased residents across
countries, 576 with relative responses.
Data Analyses
Each country will enter survey data in LimeSurvey, a secure open
source survey application. Double data entry is required for 5% of
questionnaires (random selection) so as to assess accuracy and to
avoid typing errors. If a double entry does not match the original on
fewer than 3% of the total number of data entries, the respective
partner will be asked to correct the errors. If the number of errors on
any given questionnaire exceeds 3% of entries, all questionnaires must
be re-entered.
Analyses will focus on describing and comparing countries in
terms of resident outcomes and care processes (quality of palliative/
end-of-life care) (research question 1), and in terms of palliative
care structures/systems at country/facility level, and staff knowl-
edge and attitudes (research question 2). We also aim to identify the
characteristics most strongly related to better outcomes for resi-
dents, that is, country (eg, palliative care systems), facility (eg, fa-
cility type, palliative care policies, and structures), staff (eg,
attitudes), patient (eg, functional status, having dementia or not), or
care characteristics (perceived quality) (research question 3). As
data collected in PACE are nested data (with multiple levels: resi-
dent, staff member, facility type, facility, and country), hierarchical
analysis techniques will be used such as cluster-robust standard
errors or multilevel models as appropriate in various stages of the
analyses. An in-depth nonresponse analysis will be performed, as
well as missing data analyses.
With regard to cost calculations, we will make an inventory of vol-
umes of care based on the RUD instrument (Resource Utilization in
Dementia27) and costs of speciﬁc treatments in the last month of life.
Prices will be calculated preferably by using unit cost prices per country.
In the absence of unit cost data from all participating countries, a
standard price vector based on the prices of one reference country (eg,
the Netherlands) will be used for all. This price vector will be adjusted
for differences in price levels across countries using the technique of
purchasing power parity, see for example Adang and Borm.28 The cost
calculationwill be the product of prices and country-speciﬁc volumes of
care. To determine whether care homes with higher levels of palliative
care development are more efﬁcient than care homes with lower levels
and which factors inﬂuence the (difference in) efﬁciency, we will
perform a 2-stage approach by using stochastic (bootstrapped) data
envelopment analysis (stage 1) and Tobit or truncated regression (stage
2) with potential confounders and case mix variables as covariates
(ﬁxed effect). In this way, we ascribe any differences found primarily to
systemic differences between countries.
Ethical and Legal Issues
All countries obtained ethical approval from the relevant ethics
committee in the country or university, except in the Netherlands and
Italy where this is not needed because retrospective data of deceased
residents are used (ethical committees were informed in these coun-
tries to judge whether or not formal ethical approval is needed and a
waiver can be provided). The care home directors provide informed
consent in writing. The questionnaires sent to the participants in the
surveys are anonymous and do not collect identiﬁable data of
Table 2
Measurements, Units of Analysis, Respondents, and Measurement Instruments in the Study
Measurement Unit of Analysis* Respondent* Measurement Instruments
Primary and secondary outcomes
Quality of dying of the residents Deceased resident Staff
Relative
End-of-Life in Dementia ScaleseComfort
assessment while dying (EOLD-CAD31,32)
Quality of Dying Long-Term Care (QoD LTC)33
Resident’s health-related quality of life in last
week of life
Deceased resident Staff
Relative
EuroQoL EQ-5D-5L (http://www.euroqol.org/)
Relative’s health-related quality of life Relative Relative EuroQoL EQ-5D-5L (http://www.euroqol.org/)
Palliative and end-of-life care processes and quality
Quality of palliative care Deceased resident Relative End-of-Life in Dementia ScaleseSatisfactionWith
Care (EOLD-SWC)31,32
Palliative care received Deceased resident Staff Country-speciﬁc questions depending on the
services available (eg, presence of specialist
palliative care in care homes)
Psychosocial interventions and religious/
spiritual care
Advance care planning and advance directives Deceased resident Staff
Relative
Based on Belgian survey in care homes8
Communication with family about the resident Deceased resident Relative Family Perception of Physician-Family
Communication (FPPFC)34
Possibly life-prolonging treatments (artiﬁcial
food or ﬂuid, ventilation, CPR, blood
transfusion, antibiotics etc), hospitalizations
Deceased resident Staff
Physician
Based on Belgian survey in care homes14 and end-
of-life decisions survey in several EU
countries35
Treatments discontinued or not initiated
Palliative sedation
Medication of the resident (opioids,
antipsychotics, hypnotics, sedatives)
Deceased resident Staff Proposal made by consortium
Costs, resource use
Health care resource use last month of life Deceased resident Staff Resource Utilization in Dementia RUD 3.2 (part
A2.1 and A2.2)27
Staff knowledge and attitudes toward palliative care
Palliative care knowledge Care home staff Care home staff Palliative Care Survey (PCS)36
Attitudes toward palliative care Move2pz37
Self-efﬁcacy (staff conﬁdence in providing
palliative care)
Self-Efﬁcacy in End-of-Life Care Survey
(S-EOLC)38
Interdisciplinary communication and ethical
work environment
Items selected from the Interprofessional Practice
and Education Quality Scales (IPEQS)39 Ethical
Climate Questionnaire40
Patients and family communication and
cultural ethical values
End-of-Life Professional Caregiver Survey
(EPCS)41
Structural and facility level characteristics
Palliative care systems in a country (the
existence of legislation, regulations, and
funding mechanisms for palliative care in care
homes; whether or not palliative care
initiatives are systematically implemented in
a country in this setting)
Country PACE consortium member Proposal made by consortium
Facility status (see Figure 1), type (see Table 1),
case-mix, size, average length of stay, stafﬁng,
and educational level of personnel
Facility Key management person Proposal made by consortium
Palliative care policies in the facility Facility Key management person Based on Belgian survey42
Palliative care structures in the facility:
Infrastructure and access to palliative care
Facility Key management person EU FP7 IMPACT Structural Quality Indicators for
palliative care43
Clinical and background characteristics
Comorbidities and cause of death Deceased resident Staff
Physician
Based on Belgian survey in care homes14
Expectation of death of resident Deceased resident Staff
Physician
Relative
Based on Dutch survey in nursing homes19
Functional and cognitive status Deceased resident Staff Bedford Alzheimer Nursing Severity-Scale
(BANS-S)44
Clinical judgments on dementia and stage of
dementia
Deceased resident Staff
Relative/Physician
Global Deterioration Scale stage 7 (GDS)45
Cognitive Performance Scale (CPS)46
Overall clinical judgment
Sentinel events in last month of life (eg,
pneumonia, febrile episode, eating or
drinking problem) and treatment
Deceased resident Staff As used in the US CASCADE study47
Goal of treatment last week of life (curative,
life-prolonging, maintaining function,
maximizing comfort)
Deceased resident Physician Based on care goals literature48
Background characteristics (eg, age, gender)
and relationship to deceased
Deceased resident Relative
Physician
Proposal made by consortium
Background characteristics of deceased
resident (timing of admission, place of death,
sociodemographics, socioeconomic status,
religion/ethnicity)
Deceased resident Staff
Key management person
Relative
Proposal made by consortium
(continued on next page)
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Table 2 (continued )
Measurement Unit of Analysis* Respondent* Measurement Instruments
Background characteristics care home staff
(age, gender, experience, level of education,
palliative care training)
Deceased resident
Staff
Staff Proposal made by consortium
Background characteristics physician (age,
gender, experience, palliative care training)
Deceased resident Physician Proposal made by consortium
*Care home staff, care assistants, nurses, and head nurses employed in the care home and on duty at the time of researcher’s visit; Physician, GP or elderly care physician;
Staff, staff member most involved in care for that resident (preferably a nurse)
L. Van den Block et al. / JAMDA 17 (2016) 566.e1e566.e7566.e6respondents or residents. All participants take part on a voluntary basis;
hence, their written responses will be taken as valid informed consent.
To protect residents’ personal data, the lists of those selected for
research and the questionnaires are pseudonymized at the LTCF level.
The pseudonymization key is kept by the care home directors. The
involved researchers will not be informed of the deceased residents’
identity or other personal data that can reveal their identity. Although
sensitive and disturbing questionswill be avoided in the questionnaires,
some respondents (eg, close relatives) may still become distressed by
some questions. Insurance coverage is provided by each participating
partner (usually within the frame of the general university insurance).
To handle any signs of distress of the relatives receiving the question-
naires, contact details of the researchers will be clearly mentioned, a
written protocol for dealing with queries and distress is made available
for all researchers involved in data collection, and all researchers will
keep a communication log record about the conversations.Discussion
This PACE study will result in the ﬁrst large-scale international
database describing and evaluating quality and costs of palliative care
in several types of care homes in Europe, based on representative
samples of care homes in 6 EU countries. The PACE methodology
described in this protocol can inform other countries on how to
initiate analogous representative research in these settings. For as far
as we know, such rich data collection integrating structural, system-
level data with quality and costs of care, and relating these to resi-
dent outcomes, has not been done before. The different countries
selected (Belgium, Finland, Italy, the Netherlands, Poland, and the
United Kingdom) are a good spread of countries on a number of
important parameters: they cover Northern, Western, Eastern, and
Southern Europe; include countries with varying histories of
economic growth, with different types of health care systems and
long-term care systems in particular;30 and with different levels of
development of palliative care.6 This can inform a large number of
other countries that can use this methodology to perform analogous
representative research in these complex settings.
An important strength is the measurement of outcomes (eg,
quality of dying) as well as care processes (eg, quality of care), staff
competence and attitudes toward palliative care, and care home
structures/characteristics (eg, facility type, educational level of staff)
and costs, making it possible to analyze associations between these
different levels and make hypotheses about which palliative care
practices might effectuate better outcomes in these settings. The
challenge to provide high-quality palliative care in care homes is great
in all EU countries. Palliative carewas originally developed for and still
is mainly provided to patients with end-stage cancer, who typically
have short and well-deﬁned end-of-life trajectories, contrary to many
older people in care homes, who have needs that ﬂuctuate over a long
period of time and trajectories that are difﬁcult to predict. This has
resulted in a lack of focus on palliative care in care homes and the
question remains what are the optimal systems for palliative care in
care homes.The main limitation of the study is the cross-sectional study
design. This will allow description and comparison of countries on a
number of characteristics and outcomes, and to ﬁnd associations
between structures, processes, and outcomes of care. However,
such data cannot detect cause-and-effect relationships; they can
lead only to the formulation of hypotheses about what is needed to
achieve better outcomes in care home residents. Another limitation
concerns the retrospective design and the use of proxy re-
spondents. Research has shown that the congruence between pa-
tients and proxies concerning subjective variables such as
symptoms or quality of life is not always high.29 Additionally, re-
spondents need to recall different elements of the care provided up
to three months earlier, hence some memory bias cannot be
excluded. However, the use of multiple perspectives in this study
(physicians, staff, and relatives) is an important advantage adding
to the reliability of the data.
There are also a number of important challenges related to per-
forming representative research in these settings. One of the main
difﬁculties of the study design is the identiﬁcation of a representative
sampling frame for each country. In some countries (eg, Belgium or
Poland) public lists are available of all individual care homes in the
country, whereas in other countries (eg, the Netherlands) a lot of
extra effort will be needed to prepare a full list of available facilities
in the country, or alternative sampling frames will need to be iden-
tiﬁed (eg, Italy). The long distances between care homes in some
countries (eg, Finland, Italy, Poland, United Kingdom) and the lack of
strong research tradition in care homes in some countries, makes
data collections very time-consuming. The analyses of the results will
include an in-depth nonresponse analysis to optimally understand
the representativeness of the obtained samples for each country. A
particular additional challenge in this comparative research is the
large diversity in sizes, organizational structures, funding mecha-
nisms, and populations in care homes in Europe, making cross-
country comparisons difﬁcult, with multiple factors and levels
needed to take into account.Conclusion
More and more people will live to a very old age in Europe and
many of them will develop severe functional and cognitive de-
ﬁciencies in the last years of life. The number of people dying in care
homes after being admitted for a relatively short period is predicted to
increase substantially. Hence, this study is timely and aims to opti-
mally inform policy- and decision-makers at international but also at
national and regional levels on the current state of affairs of dying in
care homes and the possible beneﬁts of different systems of care
provision. Using the results of the 6-country study, we hope to provide
important recommendations that can also apply to other countries
with similar health and long-term care systems as those of the
countries involved in PACE. The PACE methodology can also serve as a
reference for other countries that wish to initiate large-scale repre-
sentative end-of-life care research in these settings.
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